Tylenol and Autism: New Findings and Ongoing Concerns
A 2024 study found no link between acetaminophen use during pregnancy and autism, despite ongoing concerns and conflicting reports regarding prenatal exposure and autism risk.
BBC NewsTylenol-maker shares hit after report RFK Jr will suggest autism link
NBC NewsWhat the science says about acetaminophen, pregnant mothers and autism
Daily BeastAnti-Vax RFK Jr. Plans to Blame Over-the-Counter Pain Medication for Autism
Washington ExaminerTylenol stock price crashes as RFK Jr. reportedly links to autism
Overview
A 2024 study involving 2.4 million Swedish children found no connection between acetaminophen use during pregnancy and autism.
The Wall Street Journal reported potential links between autism, Tylenol use during pregnancy, and low folate levels, suggesting folate-derived medicine as a treatment.
Recent literature reviews have raised concerns about prenatal acetaminophen exposure and its possible association with autism.
The CDC reports that autism affects 1 in 31 American school-age children, highlighting challenges in communication and social behavior.
Tylenol's stock dropped over 12% following reports of potential links to autism, influenced by Secretary Robert F. Kennedy Jr.'s findings.
Analysis
Center-leaning sources frame this story by consistently emphasizing the lack of scientific evidence supporting a causal link between Tylenol and autism. They prioritize official medical and industry statements, alongside recent studies that refute the connection, while presenting claims of a link as speculative or lacking scientific basis. This collective editorial approach guides the reader towards a conclusion that the concerns are unfounded.